Literature DB >> 34331697

Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.

Mohammad Amin Khodadadegan1, Shakiba Azami1, Paul C Guest2, Tannaz Jamialahmadi3,4, Amirhossein Sahebkar5,6,7,8.   

Abstract

Depressive and anxiety disorders affect a significant proportion of the global population and constitute one of the highest disease burdens worldwide. Conventional pharmacological treatments are traditionally the first line of therapy for individuals affected by these conditions although these are only successful approximately half of the time and are often associated with undesirable side effects. This review describes the use of the natural substance curcumin as a potential alternative treatment of these mental disorders. With this in mind, we analyzed the effects of curcumin in eight clinical studies of depression and five studies of anxiety and assessed these using psychiatric symptom scores and molecular biomarker readouts.
© 2021. The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Add-on treatment; Antidepressant; Anxiety; Axiolytic; Curcumin; Depression; MDD; Therapy

Mesh:

Substances:

Year:  2021        PMID: 34331697     DOI: 10.1007/978-3-030-56153-6_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  64 in total

Review 1.  Clozapine withdrawal resulting in delirium with psychosis: a report of three cases.

Authors:  J K Stanilla; J de Leon; G M Simpson
Journal:  J Clin Psychiatry       Date:  1997-06       Impact factor: 4.384

2.  What is a mental/psychiatric disorder? From DSM-IV to DSM-V.

Authors:  D J Stein; K A Phillips; D Bolton; K W M Fulford; J Z Sadler; K S Kendler
Journal:  Psychol Med       Date:  2010-01-20       Impact factor: 7.723

3.  The effects of psychotherapy for depression on anxiety symptoms: a meta-analysis.

Authors:  Erica Weitz; Annet Kleiboer; Annemieke van Straten; Pim Cuijpers
Journal:  Psychol Med       Date:  2018-01-24       Impact factor: 7.723

Review 4.  Diagnostic criteria as dysfunction indicators: bridging the chasm between the definition of mental disorder and diagnostic criteria for specific disorders.

Authors:  Michael B First; Jerome C Wakefield
Journal:  Can J Psychiatry       Date:  2013-12       Impact factor: 4.356

5.  Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial.

Authors:  Jayesh Sanmukhani; Vimal Satodia; Jaladhi Trivedi; Tejas Patel; Deepak Tiwari; Bharat Panchal; Ajay Goel; Chandra Bhanu Tripathi
Journal:  Phytother Res       Date:  2013-07-06       Impact factor: 5.878

6.  Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders.

Authors:  Susan A Murphy; David W Oslin; A John Rush; Ji Zhu
Journal:  Neuropsychopharmacology       Date:  2006-11-08       Impact factor: 7.853

7.  The effects of chronic medical conditions on work loss and work cutback.

Authors:  R C Kessler; P E Greenberg; K D Mickelson; L M Meneades; P S Wang
Journal:  J Occup Environ Med       Date:  2001-03       Impact factor: 2.162

Review 8.  The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.

Authors:  Zachary Steel; Claire Marnane; Changiz Iranpour; Tien Chey; John W Jackson; Vikram Patel; Derrick Silove
Journal:  Int J Epidemiol       Date:  2014-03-19       Impact factor: 7.196

9.  Development of mental disorders one year after exposure to psychosocial stressors; a cohort study in primary care patients with a physical complaint.

Authors:  Lilli Herzig; Nicole Mühlemann; Bernard Burnand; Bernard Favrat; Nader Haftgoli; François Verdon; Thomas Bischoff; Paul Vaucher
Journal:  BMC Psychiatry       Date:  2012-08-20       Impact factor: 3.630

10.  Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review.

Authors:  P L de Zwart; B F Jeronimus; P de Jonge
Journal:  Epidemiol Psychiatr Sci       Date:  2018-05-17       Impact factor: 6.892

View more
  1 in total

1.  Non-micronized and micronized curcumin do not prevent the behavioral and neurochemical effects induced by acute stress in zebrafish.

Authors:  Adrieli Sachett; Matheus Gallas-Lopes; Radharani Benvenutti; Matheus Marcon; Amanda M Linazzi; Gean P S Aguiar; Ana P Herrmann; J Vladimir Oliveira; Anna M Siebel; Angelo Piato
Journal:  Pharmacol Rep       Date:  2022-07-19       Impact factor: 3.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.